Private equity should not be allowed to buy a hospital, pull value out through debt and real-estate deals, cut the resources needed for care, and then leave patients and communities holding the wreckage. That is not ordinary business risk. It is a transfer of risk from investors—who chose the deal—to people who may have no other emergency room.
Sen. Ed Markey and Rep. Pramila Jayapal reintroduced the Health Over Wealth Act on July 23, 2026. The bill would require private-equity-owned healthcare companies to disclose debt, executive pay, lobbying, political spending, patient costs and service cuts. It would also require five years of operating expenses in escrow, prohibit asset stripping and let the Department of Health and Human Services revoke investment licenses when firms price-gouge, understaff or block access to care.
Those are aggressive rules. Good. Healthcare is one of the places where aggressive guardrails are justified, because the downside of a bad acquisition is not merely a disappointing quarterly return. It can be a closed maternity ward, fewer nurses on a night shift or a longer drive during a medical emergency.
The case: patients are not a financial input
The evidence is not identical across every healthcare sector, and responsible reporting should say so. A 2026 JAMA Health Forum study, for example, found no meaningful short-term change in acute-care outcomes after private-equity acquisitions of primary-care practices. But the broader record is far too troubling for lawmakers to keep treating transparency and continuity-of-care reserves as radical ideas.
The Government Accountability Office reported that private-equity ownership or investment reached about 6.5% of physicians nationally in 2024. Its review found some evidence of higher commercial-insurance prices after private-equity investment, while also warning that rigorous research on quality and access remains limited. That uncertainty is an argument for disclosure and oversight—not for letting opaque ownership structures expand unchecked.
Hospital evidence is harder to shrug off. An Agency for Healthcare Research and Quality summary of a peer-reviewed JAMA study says Medicare patients at private-equity-acquired hospitals experienced a 25% increase in hospital-acquired conditions relative to matched controls. A bipartisan Senate Budget Committee investigation, based on more than one million pages of documents, concluded that private-equity investment in healthcare harmed patients, degraded care and helped drive hospital closures.
An advocacy-group analysis released in June adds a price warning. The nonpartisan Campaign for Accountability reported that private-equity-owned hospitals netted $669 more per patient than comparable hospitals, with no statistically significant reduction in operating costs per patient to explain the difference. That is one watchdog’s analysis, not a final universal verdict. But it lands in a pattern that policymakers would be negligent to ignore.
Why real-estate engineering belongs in the argument
One of the ugliest tricks in healthcare finance is the sale-leaseback. A hospital operator sells the land and buildings, often to a real-estate investment trust, collects cash and then saddles the hospital with rent. Investors can book value immediately while the care system inherits a fixed obligation that competes with staffing, equipment and services.
Supporters call this a way to unlock capital. In an office portfolio, that can be a defensible trade. In a hospital, the property is inseparable from the public service. An emergency department cannot move to a cheaper storefront when rent spikes. A community cannot replace an intensive-care unit with an app. Treating the building as a chip to cash out while pretending the medical operation will bear the cost forever is financial engineering with a body count risk.
The Health Over Wealth Act would close tax loopholes that encourage healthcare property sales and bar firms from stripping assets in ways that undermine quality, safety or access. Congress should go further and make owners, controlling investors and executives personally accountable when they extract dividends or fees from a facility that later cannot meet basic continuity-of-care obligations.
The counterpoint deserves a fair hearing
Private equity’s strongest defense is not absurd. Some hospitals and physician groups are already fragile. They need capital, purchasing power, better systems and disciplined management. A blanket ban could block useful investment, and ownership labels alone do not prove why a particular patient outcome changed. Public, nonprofit and corporate hospitals can also overcharge, understaff and fail.
But that defense supports carefully conditioned capital—not a blank check. If a firm believes its operating expertise will improve care, it should accept transparent debt, staffing and fee disclosures. If it believes a hospital will remain viable, it should be willing to fund a continuity reserve. If a deal works only when the buyer can sell the real estate, load the operator with rent, collect management fees and walk away before the consequences arrive, the deal does not deserve public deference.
What to do with this
Lawmakers should pass the core provisions of the Health Over Wealth Act and strengthen enforcement so penalties cannot be treated as another cost of doing business. State regulators should demand the same information before approving healthcare transactions: who ultimately controls the entity, how much debt the deal adds, what fees flow to related parties, whether property will be sold, what staffing or service reductions are planned and who pays if the operator fails.
Patients and workers cannot audit a fund structure from the waiting room. Regulators can. The moral outrage here is not that investors want returns. It is that American law still too often permits returns to be taken first while care, wages, rent obligations and collapse risk are pushed onto everyone else.
Bottom line
A hospital is not a collection of assets waiting to be optimized. It is a promise that care will be there when a community needs it. Any investor unwilling to protect that promise—with disclosure, reserves, limits on extraction and real accountability—should not be allowed to own the hospital in the first place.
